No Data
No Data
Express News | Collegium: Hikma Will Have Exclusive Right to Sell Authorized Generic Versions of Nucynta & Nucynta Er in U.S.
Express News | Collegium Announces Authorized Generic Agreement With Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® Er
Investors Don't See Light At End Of Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) Tunnel
Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) price-to-sales (or "P/S") ratio of 2.1x might make it look like a buy right now compared to the Pharmaceuticals industry in the United States, where arou
Collegium to Report First Quarter 2024 Financial Results on May 9, 2024
STOUGHTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (NASDAQ:COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious
Express News | Collegium Pharmaceutical Inc: Has Called All $26.35 Mln Aggregate Principal Amount of Its Outstanding 2.625% Convertible Senior Notes Due 2026
Express News | Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
No Data